1. IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.

    In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
    Dismiss Notice

Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses

Discussion in 'Lexicon Pharmaceuticals' started by anonymous, May 3, 2024 at 1:17 PM.

Tags: Add Tags
  1. #1 anonymous, May 3, 2024 at 1:17 PM
    anonymous

    anonymous Guest

    In case you were wondering why Coats got fired, er, retired.


    https://www.zacks.com/amp/stock/news/2267479/lexicon-pharmaceuticals-lxrx-reports-q1-loss-misses-revenue-estimates

    Lexicon Pharmaceuticals (LXRX - Free Report) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.

    This quarterly report represents an earnings surprise of -11.11%. A quarter ago, it was expected that this drugmaker would post a loss of $0.23 per share when it actually produced a loss of $0.20, delivering a surprise of 13.04%.

    Over the last four quarters, the company has surpassed consensus EPS estimates two times.

    Lexicon, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.13 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 3.09%. This compares to year-ago revenues of $0.02 million.
     
    Quote

  2. #2 anonymous, May 4, 2024 at 2:39 AM
    anonymous

    anonymous Guest

    Impressive sakes growth. Maybe the company can break $100 million revenue in 30 years or so.
     
    Quote
Reply to Thread